Influence of chain length on the activity of tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4)

被引:5
|
作者
Baumann, Markus [1 ,2 ]
Hussain, Mohammad Musarraf [1 ,2 ,5 ]
Henne, Nina [1 ,2 ]
Garrote, Daniel Moya [1 ,2 ]
Karlshoj, Stefanie [3 ]
Fossen, Torgils [1 ,2 ]
Rosenkilde, Mette M. [3 ]
Vabeno, Jon [4 ]
Haug, Bengt Erik [1 ,2 ]
机构
[1] Univ Bergen, Dept Chem, Allegaten 41, NO-5007 Bergen, Norway
[2] Univ Bergen, Ctr Pharm, Allegaten 41, NO-5007 Bergen, Norway
[3] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, Blegdamsvej 3, DK-2200 Copenhagen, Denmark
[4] UiT Arctic Univ Norway, Dept Pharm, Fac Hlth Sci, NO-9037 Tromso, Norway
[5] Jagannath Univ, Dept Pharm, Dhaka 1100, Bangladesh
基金
英国医学研究理事会;
关键词
CXCR4; antagonist; Peptidomimetic; Scaffold; SOLID-PHASE SYNTHESIS; PEPTIDE-HETEROCYCLE HYBRIDS; CELL FUSION; INHIBITOR; SDF-1; COMBINATION; LESTR/FUSIN; TACHYPLESIN; HEMOCYTES; DESIGN;
D O I
10.1016/j.bmc.2016.11.036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Here we report a series of close analogues of our recently published scaffold-based tripeptidomimetic CXCR4 antagonists, containing positively charged guanidino groups in R-1 and R-2, and an aromatic group in R-3. While contraction/elongation of the guanidine carrying side chains (R-1 and R-2) resulted in loss of activity, introduction of bromine in position 1 on the naphth-2-ylmethyl moiety (R-3) resulted in an EC50 of 61 mu M (mixture of diastereoisomers) against wild-type CXCR4; thus, the antagonistic activity of these tripeptidomimetics seems to be amenable to optimization of the aromatic moiety. Moreover, for analogues carrying a naphth-2-ylmethyl substituent, we observed that a Pictet-Spengler like cyclization side reaction depended on the nature of the R1 substituent. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:646 / 657
页数:12
相关论文
共 50 条
  • [1] Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4)
    Zachariassen, Zack G.
    Thiele, Stefanie
    Berg, Erik A.
    Rasmussen, Pernille
    Fossen, Torgils
    Rosenkilde, Mette M.
    Vabeno, Jon
    Haug, Bengt Erik
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (17) : 4759 - 4769
  • [2] Synthesis of a novel tripeptidomimetic scaffold and biological evaluation for CXC chemokine receptor 4 (CXCR4) antagonism
    Baumann, Markus
    Nome, Lina Marie
    Zachariassen, Zack G.
    Karlshoj, Stefanie
    Fossen, Torgils
    Rosenkilde, Mette M.
    Vabeno, Jon
    Haug, Bengt Erilc
    [J]. TETRAHEDRON, 2017, 73 (27-28) : 3866 - 3877
  • [3] Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4)
    Oishi, Shinya
    Fujii, Nobutaka
    [J]. ORGANIC & BIOMOLECULAR CHEMISTRY, 2012, 10 (30) : 5720 - 5731
  • [4] CXC chemokine receptor 4 (CXCR4) functions as a lactoferrin receptor in macrophages
    Takayama, Y.
    Aoki, R.
    [J]. FEBS OPEN BIO, 2018, 8 : 376 - 376
  • [5] CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment
    Bao, Shunshun
    Darvishi, Mohammad
    Amin, Ali
    Al-Haideri, Maysoon T.
    Patra, Indrajit
    Kashikova, Khadisha
    Ahmad, Irfan
    Alsaikhan, Fahad
    Al-qaim, Zahraa Haleem
    Al-Gazally, Moaed E.
    Kiasari, Bahman Abedi
    Tavakoli-Far, Bahareh
    Sidikov, Akmal A.
    Mustafa, Yasser Fakri
    Akhavan-Sigari, Reza
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 7945 - 7968
  • [6] CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment
    Shunshun Bao
    Mohammad Darvishi
    Ali H Amin
    Maysoon T. Al-Haideri
    Indrajit Patra
    Khadisha Kashikova
    Irfan Ahmad
    Fahad Alsaikhan
    Zahraa Haleem Al-qaim
    Moaed E. Al-Gazally
    Bahman Abedi Kiasari
    Bahareh Tavakoli-Far
    Akmal A. Sidikov
    Yasser Fakri Mustafa
    Reza Akhavan-Sigari
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 7945 - 7968
  • [7] SCAFFOLD-BASED TRIPEPTIDOMIMETIC CXCR4 ANTAGONISTS
    Haug, B. E.
    Baumann, M.
    Karlshoj, S.
    Rosenkilde, M. M.
    Vabeno, J.
    [J]. JOURNAL OF PEPTIDE SCIENCE, 2016, 22 : S170 - S170
  • [8] Probing the Molecular Interactions between CXC Chemokine Receptor 4 (CXCR4) and an Arginine-Based Tripeptidomimetic Antagonist (KRH-1636)
    Zachariassen, Zack G.
    Karlshoj, Stefanie
    Haug, Bengt Erik
    Rosenkilde, Mette M.
    Vabeno, Jon
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (20) : 8141 - 8153
  • [9] Drug Discovery Research Targeting the CXC Chemokine Receptor 4 (CXCR4)
    Choi, Won-Tak
    Duggineni, Srinivas
    Xu, Yan
    Huang, Ziwei
    An, Jing
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (03) : 977 - 994
  • [10] CXCR4 chemokine receptor antagonists: perspectives in SCLC
    Burger, Jan A.
    Stewart, David J.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (04) : 481 - 490